A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting β-agonists and corticosteroids

Archives of Disease in Childhood

Volumn 95, Issue 10, 2010, Pages 817-821

  Elkout, H ^a   McLay, James S ^a   Simpson, C R ^a,b   Helms, P J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; LONG ACTING DRUG; MOMETASONE FUROATE; SALMETEROL;

ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; DISEASE CONTROL; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 77953250548     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.179069     Document Type: Article

References (47)

1. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002;57:880-4.
2. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis 1992;146:547-54.
3. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-91.
4. British Thoracic Society. British guidelines on the management of bronchial asthma. BTS/SIGN. http://www.brit-thoracic.org.uk/clinical- information/asthma/asthma-guidelines.aspx (accessed 26 February 2009).
5. US Department of Health & Human Services. National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR-3). http://www.nhlbi.nih.gov/guidelines/asthma/index.htm (accessed 13 April 2009).
6. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. http://www.ginasthma.com/Guidelineitem.asp??l1= 2&l2=1&intId=1561 (accessed 13 April 2009).
7. van Noord JA, Schreurs AJ, Mol SJ, et al. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax 1999;54:207-12.
8. Kelsen SG, Church NL, Gillman SA, et al. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial. J Asthma 1999;36:703-15.
9. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164:1392-7.
10. Pauwels RA, Löfdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-11.
11. Murray JJ, Church NL, Anderson WH, et al. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases. Allergy Asthma Proc 1999;20:173-80.
12. Zimmerman B, D'Urzo A, Bérubé D. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma. Pediatr Pulmonol 2004;37:122-7.
13. Verberne AAPH, Frost C, Duivermand EJ, et al. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. Am J Respir Crit Care Med 1998;158:213-9.
14. Stempel DA, Stoloff SW, Carranza Rosenzweig JR, et al. Adherence to asthma controller medication regimens. Respir Med 2005;99:1263-7.
15. Gappa M, Zachgo W, von Berg A, et al.; VIAPAED Study Group. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial. Pediatr Pulmonol 2009;44:1132-42.
16. Jenkins C, Woolcock AJ, Saarelainen P, et al. Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma. Respir Med 2000;94:715-23.
17. Johansson G, McIvor RA, D'Ambrosio FP, et al. Comparison of salmeterol/fluticasone propionate combination with budesonide in patients with mild-tomoderate asthma. Clin Drug Investig 2001;21:633-42.
18. Shapiro G, Lumry W, Wolfe J, et al. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med 2000;161:527-34.
19. Kavuru M, Melamed J, Gross G, et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000;105:1108-16.
20. Nathan RA, Rooklin A, Schoaf L, et al. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Clin Ther 2006;28:73-85.
21. Nelson HS, Chapman KR, Pyke SD, et al. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol 2003;112:29-36.
22. Profita M, Gagliardo R, Di Giorgi R, et al. Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics. Allergy 2005;60:323-9.
23. Practice Team Information database. ISD Scotland 2009 update. http://www.isdscotland.org/isd/1044.html (accessed 4 April 2009).
24. Walsh LJ, Wong CA, Cooper S, et al. Morbidity from asthma in relation to regular treatment: a community based study. Thorax 1999;54:296-300.
25. Mäkelä MJ, Virta L, Kaila M, et al. Medication use in children with asthma in Finland from 1995 to 2006. J Allergy Clin Immunol 2008;122:648-9.
26. Bisgaard H, Szefler S. Long-acting beta2 agonists and paediatric asthma. Lancet 2006;367:286-8.
27. Phillips CB, Toyne H, Ciszek K, et al. Trends in asthma medication use among school-entry children in the Australian Capital Territory. Med J Australia 2007;187:10-13.
28. Ramirez RP, Rosenman MB, Leickly FE. Prescription patterns for asthma controller medication for children with persistent asthma: a retrospective cohort analysis of therapy before and after a change in managed care organization provider guidelines. J Allergy Clin Immunol 2008;121:220.
29. Cohen S, Taitz J, Jaffé A. Paediatric prescribing of asthma drugs in the UK: are we sticking to the guideline? Arch Dis Child 2007;92:847-9.
30. Stoloff SW, Stempel DA, Meyer J, et al. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004;113:245-51.
31. Rosenhall L, Elvstrand A, Tilling B, et al. One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma. Respir Med 2003;97:702-8.
32. Delea TE, Hagiwara M, Stanford RH, et al. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Clin Ther 2008;30:560-71.
33. Chan J, Hui RL, Spence MM. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids. J Manag Care Pharm 2007;13:21-7.
34. Angus R, Reagon R, Cheesbrough A. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination. Int J Clin Pract 2005;59:156-62.
35. Stempel DA, Riedel AA, Carranza Rosenzweig JR. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma. Curr Med Res Opin 2006;22:463-70.
36. Zetterström O, Buhl R, Mellem H, et al. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001;18:262-8.
37. Ringdal N, Cuchalin A, Chovan L, et al. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of SeretideTM (50/250 μg bd) Diskus vs formoterol (12 μg bd) and budesonide (800 μg bd) given concurrently (both via Turbuhaler) in patients with moderate-tosevere asthma. Respir Med 2002;96:851-61.
38. Chapman KR, Ringdal N, Backer V, et al. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Can Respir J 1999;6:45-51.
39. Aubier M, Pieters WR, Schlosser NJ, et al. Salmeterol/fluticasone propionate (50/500 mg) in combination in a discus inhaler (seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med 1999;93:876-84.
40. Bateman ED, Britton M, Carrillo AJ, et al. Salmeterol/fluticasone combination inhaler. A new, effective and well tolerated treatment for asthma. Clin Drug Investig 1998;16:193-201.
41. Van den Berg NJ, Ossip MS, Hederos CA, et al. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma. Pediatr Pulmonol 2000;30:97-105.
42. Lazarus SC, Boushey HA, Fahy JV, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 2001;285:2583-93.
43. Verberne AA, Frost C, Roorda RJ, et al.; The Dutch Paediatric Asthma Study Group. One year treatment with salmeterol compared with beclomethasone in children with asthma. Am J Respir Crit Care Med 1997;156:688-95.
44. Lommatzsch M, Lindner Y, Edner A, et al. Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax 2009;64:763-69.
45. Milogram H, Bender B, Acekerson L. et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-7.
46. Shireman TI, Heaton PC, Gay WE, et al. Relationship between asthma drug therapy patterns and healthcare utilization. Ann Pharmacother 2002;36:557-64.
47. Anis AH, Lynd LD, Wang X, et al. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. Can Med Assoc J 2001;164:625-31.